Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term

The Cooper Companies (COO), a specialty medical device firm, is highlighted by Zacks as a long-term value stock, despite its #3 (Hold) Zacks Rank. This assessment is driven by its B-rated VGM and Value Style Scores, an attractive forward P/E of 15.89, and recent upward revisions to its FY2025 earnings estimate, which increased by $0.01 to $4.07 per share. With an average earnings surprise of +2.5%, COO's favorable valuation and positive earnings momentum warrant investor attention.

Analysis

The Cooper Companies (COO) is presented with a nuanced investment profile, highlighted as a long-term value stock despite its neutral Zacks #3 (Hold) rating. The company's valuation is a key point of attraction, evidenced by a forward P/E ratio of 15.89 and a 'B' grade in the Zacks Value Style Score. This positive valuation signal is accompanied by subtle but favorable earnings momentum; three analysts have revised fiscal 2025 earnings estimates upward in the last 60 days, resulting in a minor consensus estimate increase to $4.07 per share. Historically, the company has demonstrated a capacity to outperform expectations, boasting an average earnings surprise of +2.5%. The combination of a strong 'B' grade for its overall VGM (Value, Growth, Momentum) Score alongside a neutral rank suggests that while near-term catalysts may be limited, the underlying fundamentals and valuation are considered solid.

Key Decisions for Investors

• Value-oriented investors should consider COO as a potential addition to their watchlist, given its attractive forward P/E of 15.89 and favorable B-rated Value Score.
• Investors should weigh the positive valuation metrics and minor upward earnings revisions against the neutral Zacks #3 (Hold) rank, which may imply limited share price appreciation in the immediate term.
• Monitor future earnings reports to see if the company can maintain its +2.5% average positive surprise, as continued outperformance could act as a catalyst for further estimate upgrades and a potential stock re-rating.